Philip Tsai

Insider Reports History

Location
Bothell, WA
Signature
/s/ Sandra Stoneman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Philip Tsai:

Company Role Class Num Shares Value Price $ Report Date Ownership
Immunome Inc. Chief Technical Officer Common Stock 43,300 $887,216 $20.49 19 Dec 2025 Direct
Immunome Inc. Chief Technical Officer Employee Stock Option (right to buy) 190,000 29 Jul 2025 Direct

Insider Reports Filed by Philip Tsai

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IMNM Immunome Inc. 19 Dec 2025 1 +$204,900 4 Chief Technical Officer 22 Dec 2025, 07:32
IMNM Immunome Inc. 29 Jul 2025 1 $0 4 Chief Technical Officer 31 Jul 2025, 19:00
IMNM Immunome Inc. 24 Mar 2025 1 +$103,566 4 Chief Technology Officer 25 Mar 2025, 17:15
IMNM Immunome Inc. 21 Nov 2024 1 +$198,030 4 Chief Technology Officer 25 Nov 2024, 08:33
IMNM Immunome Inc. 17 Jun 2024 1 $0 4 Chief Technology Officer 18 Jun 2024, 21:08
IMNM Immunome Inc. 17 Jun 2024 0 $0 3 Chief Technology Officer 18 Jun 2024, 21:05